Lords Mark Industries Pvt Ltd

Lords Mark Industries Pvt Ltd

Fundamentals

Quick Insights

  • Established Expertise: Founded in 1998, Lord’s Mark Industries leverages 25+ years of experience from its promoters, fostering strong supplier/customer ties and product diversification. Improved Financials: Gearing reduced from 3.59x (FY23) to 1.94x (FY24 provisional) with ₹28 crore equity infusion; adjusted gearing at 0.98x and strong debt metrics. Diversified Operations: Revenue from key divisions—Paper Products (₹74.90 crore), Solar LED (₹172.22 crore, ₹1,415 crore backlog), and Pharma (₹56.45 crore order book). Growth Outlook: A robust order book and diversified portfolio ensure sustained growth and financial stability.
Market Cap-
PE Ratio-
EPS₹2.2
Dividend Yield-
Book Value₹20.17 Cr
Debt/Equity1.843
Price/Book-
Price/Sales-
Industry PE-
Sales₹422.24 Cr
Profit After Tax₹11.7 Cr
Share Capital₹56.24 Cr
Shares Outstanding-
ISININE0MPL01010
SectorPaper, LED-Solar, and Diagnostics and Medtech
Symbol-
About Company

Lord’s Mark Industries Private Limited (LMIPL), established on July 1, 1998, has its registered office in Mumbai. The company operates across multiple sectors, including the processing of continuous printed stationery, copier paper slitting, manufacturing of LED products, and the design and installation of solar lighting systems through EPC services.

Latest News
No news available.
Strengths & Weaknesses

Strengths

Established Expertise: Founded in 1998, Lord’s Mark Industries leverages 25+ years of experience from its promoters, fostering strong supplier/customer ties and product diversification.
Improved Financials: Gearing reduced from 3.59x (FY23) to 1.94x (FY24 provisional) with ₹28 crore equity infusion; adjusted gearing at 0.98x and strong debt metrics.
Diversified Operations: Revenue from key divisions—Paper Products (₹74.90 crore), Solar LED (₹172.22 crore, ₹1,415 crore backlog), and Pharma (₹56.45 crore order book).
Growth Outlook: A robust order book and diversified portfolio ensure sustained growth and financial stability.

Weaknesses

Improved Operating Cycle The operating cycle improved to 171 days in FY24 (provisional) from 176 days in FY23 and 186 days in FY22, driven by reduced inventory (103 to 82 days) and collection periods (230 to 98 days). Low counterparty risk is ensured due to a government-focused clientele.
Intense Competition and Tender-Based Revenue The company’s reliance on tender-based contracts for its paper, LED, and solar businesses makes it vulnerable to competitive pressures, which also constrain margins.
Challenges in Paper and Pharma Segments The paper industry’s cyclicality and fragmentation, particularly in the industrial paper segment, pose challenges due to competition from unorganized players. Similarly, the pharma segment, being highly regulated, requires timely approvals and licenses, which could impact future expansion.
Annual Reports
Balance SheetFY2024FY2023
Equity Capital56.2428.29
Reserves50.9119.14
Total Equity107.1547.43
Borrowings81.5172.22
Other Non-Current Liabilities00
Total Non current Liabilities81.5172.22
Borrowings115.9194.69
Provisions6.064.64
Other Current Liabilities8.9410.85
Total current Liabilities130.91110.18
Equity + Liabilities319.57229.83
Fixed Assets (incl. WIP)47.3135.19
Other Non Current Assets6.702.01
Total Non Current Assets54.0037.20
Trade Receivables145.8281.74
Cash & Cash Equivalents17.719.91
Other Current Assets101.74100.98
Total current Assets265.26192.63
Preliminary Expenses0.300
Total Assets319.57229.83
Profit & LossFY2024FY2023
Revenue from Operations422.24301.08
Growth %40.24%-
Operating Expenses386.57278.55
Growth %38.78%-
Operating Profit35.6722.53
Op. Profit Margin %8.45%7.48%
Other Income1.500.89
Finance Costs16.6011.30
Depreciation4.834.60
Profit Before Tax15.747.53
Tax4.041.85
Tax %25.67%24.58%
Profit After Tax11.705.68
Growth %106.13%-
PAT %2.77%1.89%
Diluted EPS2.20-

Shareholding Pattern

No shareholding data available.

Board of Directors
Vinay ShardaDirector Admin
Veer SinghIndependent Director
Vinod TiwariIndependent Director
Subodh GuptaIndependent Director
Manish MehtaIndependent Director
Senior Management
Dr. Sachidanand UpadhyayPromoter, MD and CEO
Manav TeliExecutive Director